30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Healthcare Services Group, Inc. trades at 28.3x earnings, 19% above its 5-year average of 23.8x, sitting at the 57th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 28%. On a free-cash-flow basis, the stock trades at 11.8x P/FCF, 56% below the 5-year average of 27.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.6B | $1.4B | $860M | $771M | $892M | $1.3B | $2.1B | $1.8B | $3.0B | $3.9B | $2.9B |
| Enterprise Value | $1.5B | $1.3B | $791M | $760M | $899M | $1.3B | $2.0B | $1.8B | $3.0B | $3.9B | $2.9B |
| P/E Ratio → | 28.32 | 23.60 | 21.92 | 19.94 | 26.09 | 27.37 | 21.29 | 27.95 | 35.87 | 44.30 | 37.30 |
| P/S Ratio | 0.89 | 0.76 | 0.50 | 0.46 | 0.53 | 0.81 | 1.19 | 0.99 | 1.49 | 2.10 | 1.84 |
| P/B Ratio | 3.28 | 2.74 | 1.72 | 1.69 | 2.09 | 2.95 | 4.37 | 3.94 | 6.80 | 9.80 | 8.49 |
| P/FCF | 11.81 | 10.04 | 35.14 | 20.24 | — | 42.44 | 9.87 | 20.33 | 39.92 | 1755.32 | 80.04 |
| P/OCF | 11.34 | 9.63 | 27.91 | 17.72 | — | 35.94 | 9.67 | 19.38 | 37.46 | 513.71 | 69.52 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Healthcare Services Group, Inc.'s enterprise value stands at 23.1x EBITDA, 57% above its 5-year average of 14.7x. The Healthcare sector median is 14.2x, placing the stock at a 62% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.69 | 0.46 | 0.45 | 0.53 | 0.78 | 1.12 | 0.99 | 1.49 | 2.11 | 1.83 |
| EV / EBITDA | 23.07 | 19.29 | 11.66 | 11.02 | 15.21 | 16.25 | 13.66 | 19.75 | 27.41 | 29.06 | 22.79 |
| EV / EBIT | 31.04 | 25.96 | 13.32 | 12.48 | 18.91 | 19.14 | 15.16 | 20.48 | 29.14 | 29.37 | 23.93 |
| EV / FCF | — | 9.05 | 32.33 | 19.96 | — | 40.76 | 9.30 | 20.33 | 39.98 | 1766.88 | 79.37 |
Margins and return-on-capital ratios measuring operating efficiency
Healthcare Services Group, Inc. earns an operating margin of 2.6%. ROE of 11.7% is modest. ROIC of 9.0% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.0% | 13.0% | 13.3% | 12.8% | 11.4% | 14.0% | 15.2% | 12.4% | 11.8% | 13.6% | 14.3% |
| Operating Margin | 2.6% | 2.6% | 3.1% | 3.3% | 2.6% | 3.9% | — | 4.2% | 5.0% | 6.8% | 7.5% |
| Net Profit Margin | 3.2% | 3.2% | 2.3% | 2.3% | 2.0% | 3.0% | 5.6% | 3.5% | 4.2% | 4.7% | 5.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.7% | 11.7% | 8.3% | 8.7% | 7.8% | 10.4% | 21.0% | 14.3% | 19.9% | 23.9% | 24.4% |
| ROA | 7.3% | 7.3% | 4.9% | 5.0% | 4.6% | 6.1% | 12.9% | 9.1% | 12.2% | 14.6% | 15.3% |
| ROIC | 9.0% | 9.0% | 9.1% | 9.3% | 7.9% | 12.7% | — | 12.9% | 17.3% | 25.7% | 30.5% |
| ROCE | 7.7% | 7.7% | 8.8% | 9.7% | 7.7% | 10.5% | — | 14.0% | 19.6% | 27.6% | 29.0% |
Solvency and debt-coverage ratios — lower is generally safer
Healthcare Services Group, Inc. carries a Debt/EBITDA ratio of 0.4x, which is very conservative (88% below the sector average of 3.2x). The company holds a net cash position — cash of $161M exceeds total debt of $25M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 30.7x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.05 | 0.03 | 0.10 | 0.08 | 0.04 | 0.03 | 0.06 | 0.07 | 0.09 | — |
| Debt / EBITDA | 0.38 | 0.38 | 0.24 | 0.63 | 0.56 | 0.23 | 0.12 | 0.29 | 0.27 | 0.26 | — |
| Net Debt / Equity | — | -0.27 | -0.14 | -0.02 | 0.02 | -0.12 | -0.26 | -0.00 | 0.01 | 0.06 | -0.07 |
| Net Debt / EBITDA | -2.09 | -2.09 | -1.01 | -0.15 | 0.12 | -0.67 | -0.85 | -0.01 | 0.04 | 0.19 | -0.19 |
| Debt / FCF | — | -0.98 | -2.81 | -0.28 | — | -1.69 | -0.58 | -0.01 | 0.05 | 11.57 | -0.66 |
| Interest Coverage | 30.72 | 30.72 | 9.22 | 7.75 | 15.92 | 48.30 | 95.02 | 25.60 | 33.29 | 98.55 | — |
Net cash position: cash ($161M) exceeds total debt ($25M)
Short-term solvency ratios and asset-utilisation metrics
Healthcare Services Group, Inc.'s current ratio of 3.38x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.64x to 3.38x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.38 | 3.38 | 2.89 | 2.64 | 2.85 | 2.86 | 3.53 | 3.47 | 3.11 | 2.86 | 4.11 |
| Quick Ratio | 3.28 | 3.28 | 2.80 | 2.55 | 2.73 | 2.72 | 3.33 | 3.22 | 2.86 | 2.63 | 3.74 |
| Cash Ratio | 1.20 | 1.20 | 0.71 | 0.68 | 0.68 | 0.97 | 1.63 | 0.79 | 0.63 | 0.45 | 0.91 |
| Asset Turnover | — | 2.27 | 2.10 | 2.08 | 2.35 | 2.09 | 2.22 | 2.52 | 2.90 | 2.76 | 2.96 |
| Inventory Turnover | 95.12 | 95.12 | 88.82 | 78.83 | 70.73 | 54.25 | 47.25 | 44.17 | 42.76 | 38.04 | 35.44 |
| Days Sales Outstanding | — | 66.51 | 81.34 | 83.75 | 74.16 | 67.18 | 52.97 | 67.60 | 62.11 | 74.07 | 63.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Healthcare Services Group, Inc. returns 3.7% to shareholders annually primarily through share buybacks. The earnings yield of 3.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | 7.1% | 4.7% | 2.9% | 3.2% | 1.9% | 1.4% | 1.9% |
| Payout Ratio | — | — | — | — | 185.1% | 128.2% | 61.5% | 91.3% | 68.5% | 62.6% | 68.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.5% | 4.2% | 4.6% | 5.0% | 3.8% | 3.7% | 4.7% | 3.6% | 2.8% | 2.3% | 2.7% |
| FCF Yield | 8.5% | 10.0% | 2.8% | 4.9% | — | 2.4% | 10.1% | 4.9% | 2.5% | 0.1% | 1.2% |
| Buyback Yield | 3.7% | 4.4% | 0.6% | 1.5% | 0.0% | 1.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.7% | 4.4% | 0.6% | 1.5% | 7.1% | 6.3% | 2.9% | 3.2% | 1.9% | 1.4% | 1.9% |
| Shares Outstanding | — | $73M | $74M | $74M | $74M | $75M | $75M | $75M | $75M | $74M | $73M |
Compare HCSG with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $2B | 28.3 | 23.1 | 11.8 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 | |
| $589M | 12.7 | 8.8 | 66.0 | 46.4% | 18.6% | 18.5% | 21.9% | 0.0 | |
| $3B | 17.0 | 9.7 | 16.7 | 11.7% | 3.7% | 9.1% | 7.5% | 3.9 | |
| $69B | 38.8 | 25.0 | 39.2 | 50.0% | 22.8% | 40.3% | 25.8% | 0.9 | |
| $466M | -4.3 | — | — | -580.2% | -4253.8% | -42.0% | -64.9% | — | |
| $61M | -7.7 | — | — | 34.1% | -10.0% | -11.8% | -8.5% | — | |
| $2B | 14.3 | 3.1 | 6.8 | 17.4% | 5.3% | 252.0% | — | 2.8 | |
| $394M | -1.6 | — | 3.5 | 20.1% | -1.6% | -23.0% | -4.0% | — | |
| $203M | -4.2 | 170.2 | — | 21.2% | -1.7% | -16.3% | -5.2% | 83.1 | |
| $426M | -4.5 | 24.0 | 10.6 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 | |
| $1B | -12.5 | 10.4 | 5.1 | 28.3% | 1.2% | -14.2% | 1.6% | 4.2 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HCSG stock.
Healthcare Services Group, Inc.'s current P/E ratio is 28.3x. The historical average is 29.0x. This places it at the 57th percentile of its historical range.
Healthcare Services Group, Inc.'s current EV/EBITDA is 23.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.9x.
Healthcare Services Group, Inc.'s return on equity (ROE) is 11.7%. The historical average is 13.5%.
Based on historical data, Healthcare Services Group, Inc. is trading at a P/E of 28.3x. This is at the 57th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Healthcare Services Group, Inc. has 13.0% gross margin and 2.6% operating margin.
Healthcare Services Group, Inc.'s Debt/EBITDA ratio is 0.4x, indicating low leverage. A ratio below 2x is generally considered financially healthy.